A 6-month fully remote weight-loss program tailored to veterans with serious mental illness yielded numerically greater ...

Around 70% of Americans are obese or overweight. And their cats aren’t too far off. According to the Association for Pet ...

A California company, Okava Pharmaceuticals, has launched a clinical trial testing a GLP-1–based weight loss treatment in 50 ...

Pennsylvania has quietly moved to limit access next year to popular weight-loss drugs like Ozempic and Wegovy for residents ...

Eli Lilly on Monday announced new price cuts for its popular weight loss drug Zepbound, broadening access for patients and driving greater use of the company’s digital healthcare platform, LillyDirect ...

Good news is coming to Medicare recipients as the list of prescription medications seeing a price drop under the Inflation Reduction Act increases. The federal government is slashing prices for 15 ...

The Trump administration on Tuesday said it will pay lower prices for 15 prescription drugs for people on Medicare, including GLP-1 medications Ozempic and Wegovy, inhaler Trelegy Ellipta and cancer ...

Nov 21 (Reuters) - Eli Lilly (LLY.N), opens new tab said on Friday it plans to roll out an employer-focused obesity care model early next year, aiming to expand access to its blockbuster weight-loss ...

(Reuters) -Eli Lilly said on Friday it plans to roll out an employer-focused obesity care model early next year, aiming to expand access to its blockbuster weight-loss drug through partnerships with ...

Javascript must be enabled to use this site. Please enable Javascript in your browser and try again. Get the AARP Now app. New and improved, it’s the app that makes ...

That's one small step for a man. One very expensive leap for the United States. Okay, sure, some would argue focusing on the total cost of the Apollo program defeats the purpose. Stepping onto the ...

Journal Editorial Report: Paul Gigot interviews Democratic Pollster Doug Schoen. New weight-loss drugs are working wonders, but they’re also out of many patients’ financial reach. Enrollees in ...